Article Information
History
- March 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bicheng Zhang*,1,
- Xiaoyang Zhou*,2,
- Chengliang Zhu*,3,
- Fan Feng1,
- Yanru Qiu1,
- Jia Feng1,
- Qingzhu Jia4,
- Qibin Song†,1,
- Bo Zhu†,4 and
- Jun Wang†,5
- 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China
- 2Cardiac Care Unit, Eastern Campus, Renmin Hospital of Wuhan University, Wuhan, China
- 3Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China
- 4Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China
- 5Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
- ↵†Correspondence to: Prof Jun Wang PhD, Department of Oncology, the First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China., ggjun2005{at}126.com or Prof Bo Zhu PhD, Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing 400038, China., bo.zhu{at}tmmu.edu.cn or Prof Qibin Song PhD, Cancer center,, Renmin Hospital of Wuhan University, Wuhan 430060, China., qibinsong{at}163.com
↵* Contributed equally
Posted March 16, 2020.
Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19
